Clinical Trials Logo

Clinical Trial Summary

Lung ultrasound (LUS) in combination with a biomarker has not yet been studied. The investigators propose a clinical trial where the primary aims are: 1. To assess whether an algorithm with LUS and procalcitonin (PCT) may be useful for diagnosing bacterial pneumonia; 2. To analyse the sensitivity and specificity of LUS vs chest radiograph (CXR).


Clinical Trial Description

Objectives: The general objective is to analyze whether a new algorithm approach of severe pneumonia in pediatric intensive unit (PICU) improves the quality of care. Objectives: 1- To analyze the sensitivity and specificity of lung ultrasound (LUS) compared respect to the chest radiography (CXR) in severe pneumonia and if LUS discriminates between bacterial and viral one. 2- If there is a lower CXR indication. 3- If is possible to reduce the dose of irradiation and costs associated with CXR. 4- To analyze the interobserver agreement of the LUS. 5- determine whether a diagnosis of pneumonia algorithm using LUS and procalcitonin may be useful in directing the indication of antibiotic therapy and / or the duration thereof.

Methodology: clinical, prospective, controlled, randomized, blinded intervention and 3-year trial. Inclusion of children under 18 years, with severe pneumonia, who enter (PICU). Experimental Group 1: pediatrician researcher (PR) will conduct a LUS at admission time, as a first test of lung image; in Group 2, CXR is conduced as first image. Patients will be classified into 3 subgroups, in both branches: a) if PCT is <1 ng /L and LUS is not suggestive of bacterial pneumonia, no antibiotic will be prescribed; b) if LUS is suggestive of bacterial pneumonia, regardless of the PCT, it will be recommended to start antibiotic therapy; c) If the ultrasound is suggestive of bacterial pneumonia but PCT is> 1 ng / L, antibiotic therapy will be recommended to cover other causes of infection. The same attitude will be performed, but depending on the CXR instead of the LUS, in group 2. Clinical variables, complementary tests and evolution data will be collected. Statistics by SPPS® 20.0. Informed consent will be requested and the study will be conducted according to the Helsinki Declaration guidelines and Good Clinical Practice. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04217980
Study type Interventional
Source Fundació Sant Joan de Déu
Contact
Status Completed
Phase N/A
Start date September 21, 2017
Completion date December 3, 2019

See also
  Status Clinical Trial Phase
Terminated NCT03929484 - A Feasibility Study Evaluating a Novel Mask (Nasal Reservoir Cannula) N/A
Active, not recruiting NCT04923035 - Paediatric Pneumococcal Pneumonia in Malaysia Prior to and During Pneumococcal Conjugate Vaccine (PCV) Implementation
Completed NCT06033079 - Improving CarE for Community Acquired Pneumonia 1 (ICE-CAP2) N/A
Completed NCT03710759 - Effect of Assisted Autogenic Drainage In Children Suffering From Pneumonia N/A
Recruiting NCT02669654 - Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children Phase 4
Recruiting NCT03446534 - The Norwegian Antibiotics for Pneumonia in Children Study Phase 4
Enrolling by invitation NCT05826873 - Discharge Stewardship in Children's Hospitals N/A
Recruiting NCT03612362 - Impact of Improved "Injera" Baking Stove Use on Childhood Acute Respiratory Infection Prevention in Northwest Ethiopia N/A
Completed NCT06174454 - Clinical Efficacy of Respiratory Pediatric Physiotherapy on a Child With Hospital Treated Pneumonia N/A
Completed NCT03760419 - Improving CarE for Community Acquired Pneumonia 1 N/A
Completed NCT06154876 - Effect Of Cough Assist Device On Hemodynamic Status And Oxygen Saturation For Ventilated Children N/A
Terminated NCT03067558 - Acute Respiratory Infection Diagnostic Aids (ARIDA) Controlled Accuracy Evaluation Protocol N/A